Medical Dialogues

Patient Wealth Impacts Glaucoma Control and Follow-Up, reveals JAMA study

Researchers have found in a new study that personal wealth is strongly associated with outcomes 12–18 months after a new ...
Physician's Weekly

Semaglutide May Raise Risk for NAION, Does Not Impact Risk for DR

The meta-analysis identified a significant association between treatment with semaglutide and risk for NAION (OR, 3.92; 95% ...

Access to ophthalmologists improved from 2014 to 2024, research shows

Overall access to ophthalmologists improved from 2014 to 2024, according to a research letter published in JAMA Ophthalmology ...

Gas-permeable lenses beneficial after congenital glaucoma surgery

For children undergoing primary congenital glaucoma (PCG) surgery, use of rigid gas-permeable contact lenses (RGPCLs) is ...
Healio

Specialists discuss concerns over impact of semaglutide on the eye

Please provide your email address to receive an email when new articles are posted on . A paper recently published in JAMA Ophthalmology by Hathaway and colleagues at Harvard suggested a potential ...
Nasdaq

JAMA Ophthalmology Publishes Pooled Analysis of Data from two Phase 3 Clinical Trials of Upneeq™ (oxymetazoline hydrochloride, 0.1% solution) for Acquired Ptosis

-- Phase 3 trials showed UPNEEQ was associated with positive outcomes after instillation on days 1 and 14 and was well-tolerated, demonstrating its potential promise for the treatment of acquired ...
Medicine Buffalo

Ophthalmic complications in patients on antidiabetic GLP-1 medications are concerning neuro-ophthalmologists

BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established.